Clinical Trials Directory

Trials / Completed

CompletedNCT00560859

Childhood Adenotonsillectomy Study for Children With OSAS

A Randomized Controlled Study of Adenotonsillectomy for Children With Obstructive Sleep Apnea Syndrome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
453 (actual)
Sponsor
University of Pennsylvania · Academic / Other
Sex
All
Age
5 Years – 9 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research is to determine the effect of adenotonsillectomy surgery (removal of tonsils and adenoids) on obstructive sleep apnea syndrome (OSAS) in children. OSAS can cause health problems including poor growth, high blood pressure, diabetes and behavioral and learning difficulties. Although adenotonsillectomy is the usual treatment for children with OSAS, it is not known with any certainty if the child's OSAS symptoms improve afterwards. This study will help determine if improvement occurs or if it does not. It will also look at whether certain groups, such as children who are overweight or of different ethnicities, are helped by the surgery.

Detailed description

Because adenotonsillectomy is the usual treatment for OSAS, all children in the study will get surgery. However, in order to assess the extent to which adenotonsillectomy surgery improves breathing disturbances and sleep quality in children with OSAS, two groups will be studied. One group will get surgery early (one month after enrollment) and the other group will be re-evaluated for surgery within 7 months of enrollment. Children in both groups will be closely monitored through the 7-8 month study period and sleep and health educational materials will be provided to assist in establishing healthy habits.

Conditions

Interventions

TypeNameDescription
PROCEDUREAdenotonsillectomy (AT) - removal of adenoids and tonsilsStandard surgical intervention for treatment of Obstructive Sleep Apnea Syndrome which includes removal of adenoids and tonsils
OTHERWatchful WaitingChildren will reevaluated for adenotonsillectomy (AT) after a 7 month primary monitoring period.

Timeline

Start date
2007-10-01
Primary completion
2012-03-01
Completion
2012-06-01
First posted
2007-11-20
Last updated
2015-12-15
Results posted
2015-12-15

Locations

6 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00560859. Inclusion in this directory is not an endorsement.